Factor VII-Antithrombin Complex Predicts Mortality in CAD

This article originally appeared here.
Share this content:
Factor VII-Antithrombin Complex Predicts Mortality in CAD
Factor VII-Antithrombin Complex Predicts Mortality in CAD

FRIDAY, Feb. 12, 2016 (HealthDay News) -- Activated factor VII-antithrombin complex (FVIIa-AT) levels correlate with increased mortality risk in patients with coronary artery disease (CAD), according to a study published online Jan. 27 in the Journal of Thrombosis and Haemostasis.

Nicola Martinelli, M.D., Ph.D., from the University of Verona in Italy, and colleagues examined FVIIa-AT plasma concentrations in 686 subjects with (546 subjects) or without (140 subjects) angiographically-proven CAD. Patients with CAD were followed for total and cardiovascular mortality.

The researchers found that FVIIa-AT levels did not differ for CAD and CAD-free subjects (84.8 and 83.9 pM, respectively). During a 64-month median follow-up, the risk of both total and cardiovascular mortality was increased two-fold for patients with FVIIa-AT levels higher than the median at baseline (≥79 pM), within the CAD population. After adjustment for sex, age, and other predictors of mortality, the results were confirmed (hazard ratio for total mortality, 2.05; hazard ratio for cardiovascular mortality, 1.94; with slight improvement of C-statistic over traditional risk factors). Increased thrombin generation was also seen in association with high FVIIa-AT levels.

"This preliminary study suggests that plasma concentration of FVIIa-AT is a thrombophilic marker of total and cardiovascular mortality risk in patients with clinically stable CAD," the authors write.

Two authors disclosed financial ties to Diagnostica Stago.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

From pre- to post-expansion period, 59 percent relative increase in Medicaid-covered preemptive listings

BCG Vaccine Tied to Reduced Hyperglycemia in Type 1 Diabetes

BCG Vaccine Tied to Reduced Hyperglycemia in Type ...

Systemic shift in glucose metabolism from oxidative phosphorylation to aerobic glycolysis

Many Physicians Not Prepared for End-of-Life Talks With Patients

Many Physicians Not Prepared for End-of-Life Talks With ...

Additional training, reimbursement may foster these critical conversations, authors say

is free, fast, and customized just for you!




Already a member?

Sign In Now »